Enovis sees 11% sales increase in Q2: 7 notes

Medical technology company Enovis saw an 11 percent increase in net sales during the second quarter of 2022, bringing its total to $395 million, according to the company’s financial results released Aug. 4. 

Advertisement

7 things to know about Enovis’ second quarter: 

1. Sales growth: On top of an 11 percent revenue increase, Enovis saw a 3 percent increase in organic growth and a 5 percent increase in sales-per-day growth. 

2. Operating income: Enovis’ operating income was $6 million. 

3. Earnings per share: Enovis’ earnings per share increased to $0.59 from $0.41 in 2021.

4. Earnings before interest, taxes, depreciation and amortization: Enovis experienced an 11% growth in EBITA, reaching $56 million in the second quarter. 

5. Acquisitions: Enovis completed the acquisition of Insight Medical Systems and 360 Med Care in quarter two. 

6. Launches: Enovis launched a new version of its custom recovery boots, ProCare MaxTrax 2.0. 

7. Future growth: Enovis is expecting a 6 to 9 percent growth throughout all of 2022.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.